EPS for Neogen Corporation (NEOG) Expected At $0.30

June 17, 2018 - By simple simple

Neogen Corporation (NASDAQ:NEOG) LogoInvestors sentiment increased to 6.71 in Q1 2018. Its up 5.22, from 1.49 in 2017Q4. It is positive, as 13 investors sold Neogen Corporation shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported.
Invesco Ltd holds 466,434 shares or 0.01% of its portfolio. 5,726 were reported by Sheets Smith Wealth Management. Susquehanna Grp Inc Llp reported 12,042 shares. Van Eck Associate Corporation invested in 93,921 shares or 0.03% of the stock. Metropolitan Life Com accumulated 15,860 shares or 0% of the stock. Hightower Ltd Llc has invested 0% in Neogen Corporation (NASDAQ:NEOG). Manchester Capital Mgmt Limited invested 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG). Massachusetts-based State Street has invested 0.01% in Neogen Corporation (NASDAQ:NEOG). 16,534 were reported by Bnp Paribas Arbitrage. Tci Wealth Advisors Inc holds 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG) for 28 shares. Etrade Management Ltd Llc reported 0.02% in Neogen Corporation (NASDAQ:NEOG). Liberty Mngmt Incorporated reported 49,403 shares stake. Principal Grp reported 412,805 shares. Bb&T Corporation holds 0.01% or 6,757 shares in its portfolio. New York-based Eulav Asset Mngmt has invested 0.13% in Neogen Corporation (NASDAQ:NEOG).

Since January 26, 2018, it had 0 insider purchases, and 16 insider sales for $10.42 million activity. $1.50M worth of Neogen Corporation (NASDAQ:NEOG) was sold by HERBERT JAMES L. PAPESH G BRUCE sold 6,000 shares worth $435,000. 7,000 shares valued at $417,223 were sold by BRADLEY EDWARD on Friday, February 16. $330,648 worth of Neogen Corporation (NASDAQ:NEOG) was sold by Quinlan Steven J. on Tuesday, March 27. BOEHM WILLIAM T sold $69,300 worth of stock or 1,020 shares. Another trade for 6,000 shares valued at $374,818 was made by REED THOMAS H on Friday, March 23.

Analysts expect Neogen Corporation (NASDAQ:NEOG) to report $0.30 EPS on July, 17.They anticipate $0.06 EPS change or 25.00 % from last quarter’s $0.24 EPS. NEOG’s profit would be $15.48 million giving it 68.23 P/E if the $0.30 EPS is correct. After having $0.32 EPS previously, Neogen Corporation’s analysts see -6.25 % EPS growth. The stock increased 1.58% or $1.27 during the last trading session, reaching $81.88. About 220,226 shares traded or 7.30% up from the average. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since June 17, 2017 and is uptrending. It has outperformed by 44.12% the S&P500.

Neogen Corporation (NASDAQ:NEOG) Ratings Coverage

Among 2 analysts covering Neogen Corp (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Neogen Corp had 2 analyst reports since January 4, 2018 according to SRatingsIntel. The firm has “Hold” rating given on Monday, March 26 by Stephens. The stock of Neogen Corporation (NASDAQ:NEOG) earned “Hold” rating by Roth Capital on Thursday, January 4.

Neogen Corporation, together with its subsidiaries, develops, makes, and markets various products for food and animal safety worldwide. The company has market cap of $4.22 billion. It operates through two divisions, Food Safety and Animal Safety. It has a 72.72 P/E ratio. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

More recent Neogen Corporation (NASDAQ:NEOG) news were published by: Nasdaq.com which released: “Market Trends Toward New Normal in Neogen, Intuitive Surgical, IDT, Government Properties Income Trust, Everbridge …” on June 13, 2018. Also Benzinga.com published the news titled: “Benzinga’s Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time” on June 01, 2018. Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” with publication date: June 15, 2018 was also an interesting one.

Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.